SCHEMBL17675169

SCHEMBL17675169

CCCCc1c(I)cnc(Cl)c1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
NFKB1 P19838 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
THPO P40225 1/20 0.40
BLM P54132 1/20 0.40
PMP22 Q01453 1/20 0.40
KMT2A Q03164 1/20 0.40
HIF1A Q16665 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1505508 0.76 SMN1; SMN2 (0.42) ALDH1A1KDM4EMEN1LMNAKMT2A
SCHEMBL845583 0.72 SMN1; SMN2 (0.36) ALDH1A1KDM4ELMNAKMT2ADPP4
SCHEMBL23776735 0.69 SMN1; SMN2 (0.34) ALDH1A1KDM4ELMNADPP4SMN1; SMN2
SCHEMBL14989307 0.69 FFAR1 (0.44) ALDH1A1NFKB1KDM4EMEN1LMNA
SCHEMBL11114754 0.69 FFAR1 (0.44) ALDH1A1NFKB1KDM4EMEN1LMNA
SCHEMBL4180060 0.69 SMN1; SMN2 (0.35) ALDH1A1KDM4EKMT2ATDP1GABRP
SCHEMBL9420032 0.69 GABRP (0.41) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL3184433 0.69 KDM4E (0.39) ALDH1A1KDM4ELMNAPKMDPP4
SCHEMBL16447451 0.69 ESR1 (0.48) ALDH1A1MEN1LMNACYP1A2CYP3A4
SCHEMBL29118334 0.68 SMN1; SMN2 (0.33) ALDH1A1KDM4ELMNASMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3203840-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2017-08-16 EP disclosed
WO-2016057572-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MILLER MARK THOMAS (US) 2016-04-14 WO disclosed